---
document_datetime: 2023-09-21 17:23:22
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/fendrix-epar-all-authorised-presentations_en.pdf
document_name: fendrix-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8793215
conversion_datetime: 2025-12-30 08:05:56.943798
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form      | Route of administration   | Immediate Packaging        | Content (concentration)   | Pack size                       |
|------------------|-------------------|------------|--------------------------|---------------------------|----------------------------|---------------------------|---------------------------------|
| EU/1/04/0299/001 | Fendrix           | - 1 -      | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe + 1 needle |
| EU/1/04/0299/002 | Fendrix           | - 1 -      | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe            |
| EU/1/04/0299/003 | Fendrix           | - 1 -      | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes          |

1

1 dose (0.5 ml) contains:

Hepatitis B surface antigen 1, 2, 3

20 micrograms

1 adjuvanted by AS04C containing:

- 3- O -desacyl-4'- monophosphoryl lipid A (MPL)  2

50 micrograms

2 adsorbed on aluminium phosphate (0.5 milligrams Al 3+  in total)

3 produced in yeast cells ( Saccharomyces cerevisiae ) by recombinant DNA technology